{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T11:06:29Z","timestamp":1788951989720,"version":"build-2803163510"},"reference-count":28,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T00:00:00Z","timestamp":1785110400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007314","name":"Duncan Family Institute for Cancer Prevention and Risk Assessment","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007314","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinical-breast-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Breast Cancer"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.clbc.2026.07.030","type":"journal-article","created":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T20:57:37Z","timestamp":1787864257000},"page":"193-198","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Effect of Germline Pathogenic Variants in the Upgrade Rate to Breast Cancer Among Patients Diagnosed With Atypical Lobular Hyperplasia and Lobular Carcinoma In Situ on Core Needle Biopsy"],"prefix":"10.1016","volume":"26","author":[{"given":"Komal","family":"Ijaz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Broden","family":"Alston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Therese","family":"Bevers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Banu","family":"Arun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"Hunt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Whitman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6445-3947","authenticated-orcid":false,"given":"Lavinia P.","family":"Middleton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.clbc.2026.07.030_bib0001","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1158\/1078-0432.CCR-18-1103","article-title":"Lobular carcinomas in situ display intralesion genetic heterogeneity and clonal evolution in the progression to invasive lobular carcinoma","volume":"25","author":"Lee","year":"2019","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.clbc.2026.07.030_bib0002","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.path.2017.09.009","article-title":"Lobular carcinoma in situ","volume":"11","author":"Wen","year":"2018","journal-title":"Surg Pathol Clin"},{"issue":"33","key":"10.1016\/j.clbc.2026.07.030_bib0003","doi-asserted-by":"crossref","first-page":"3945","DOI":"10.1200\/JCO.2015.61.4743","article-title":"Lobular carcinoma in situ: a 29-year longitudinal experience evaluating clinicopathologic features and breast cancer risk","volume":"33","author":"King","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clbc.2026.07.030_bib0004","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/1097-0142(19930101)71:1<147::AID-CNCR2820710124>3.0.CO;2-V","article-title":"Relationship between breast histopathology and family history of breast cancer","volume":"71","author":"Claus","year":"1993","journal-title":"Cancer"},{"key":"10.1016\/j.clbc.2026.07.030_bib0005","first-page":"542378","article-title":"Familiarity of cancer in Utah","author":"Cannonalbright","year":"1994","journal-title":"Cancer Res"},{"key":"10.1016\/j.clbc.2026.07.030_bib0006","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1469-1809.1990.tb00373.x","article-title":"Using age of onset to distinguish between subforms of breast cancer","volume":"54","author":"Claus","year":"1990","journal-title":"Ann Human Genet"},{"key":"10.1016\/j.clbc.2026.07.030_bib0007","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.jacr.2020.07.036","article-title":"Risk for upgrade to malignancy after breast core needle biopsy diagnosis of lobular neoplasia: a systematic review and meta-analysis","volume":"17","author":"Shehata","year":"2020","journal-title":"J Am Coll Radiol"},{"issue":"12","key":"10.1016\/j.clbc.2026.07.030_bib0008","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/jnci\/djaa023","article-title":"Association of germline pathogenic variants with breast cancer subtypes","volume":"112","author":"Hu","year":"2020","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"10.1016\/j.clbc.2026.07.030_bib0009","doi-asserted-by":"crossref","first-page":"616","DOI":"10.3390\/genes12050616","article-title":"Clinicopathologic profile of breast cancer in germline ATM and CHEK2 mutation carriers","volume":"12","author":"Toss","year":"2021","journal-title":"Genes (Basel)"},{"issue":"1","key":"10.1016\/j.clbc.2026.07.030_bib0010","first-page":"77","article-title":"Genetic\/familial high risk assessment: breast, ovarian and pancreatic version","volume":"19","year":"2021","journal-title":"J Natl Compr Cancer Netw"},{"key":"10.1016\/j.clbc.2026.07.030_bib0011","unstructured":"NCCN practice guidelines in oncology, breast cancer screening and diagnosis. Version 2.2025. 25. https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/breast-screening.pdf Accessed: December 20, 2025."},{"key":"10.1016\/j.clbc.2026.07.030_bib0012","unstructured":"American Society of Breast Surgeons Resource Guide: surgical management of benign or high-risk lesions https:\/\/www.breastsurgeons.org\/docs\/statements\/asbrs-rg-high-risk-lesions.pdf Accessed: April 12, 2026."},{"issue":"3","key":"10.1016\/j.clbc.2026.07.030_bib0013","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1002\/cam4.223","article-title":"Most lobular carcinoma in situ and atypical lobular hyperplasia diagnosed on core needle biopsy can be managed clinically with radiologic follow-up in a multidisciplinary setting","volume":"3","author":"Middleton","year":"2014","journal-title":"Cancer Med"},{"issue":"3","key":"10.1016\/j.clbc.2026.07.030_bib0014","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1245\/s10434-011-2034-3","article-title":"Lobular in-situ neoplasia on breast core needle biopsy: imaging indication and pathologic extent can identify which patients require excisional biopsy","volume":"19","author":"Rendi","year":"2012","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.clbc.2026.07.030_bib0015","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.critrevonc.2006.01.006","article-title":"Histopathology of BRCA1- and BRCA2-associated breast cancer","volume":"59","author":"Honrado","year":"2006","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.clbc.2026.07.030_bib0016","article-title":"Germline pathogenic variants and breast cancer phenotypes in a European multicenter cohort","volume":"10","author":"Rodriguez-Hernandez","year":"2025","journal-title":"ESMO Open"},{"key":"10.1016\/j.clbc.2026.07.030_bib0017","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1158\/1055-9965.EPI-18-1102","article-title":"Frequency of pathogenic germline variants in CDH1, BRCA2, CHEK2, PALB2, BRCA1, and TP53 in sporadic lobular breast cancer","volume":"28","author":"Petridis","year":"2019","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.clbc.2026.07.030_bib0018","doi-asserted-by":"crossref","first-page":"3120","DOI":"10.1245\/s10434-024-14947-0","article-title":"Upgrade rates in patients with germline pathogenic variant carriers diagnosed with high-risk breast lesions","volume":"31","author":"Laws","year":"2024","journal-title":"Ann Surg Oncol"},{"issue":"35","key":"10.1016\/j.clbc.2026.07.030_bib0019","doi-asserted-by":"crossref","first-page":"3918","DOI":"10.1200\/JCO.21.00640","article-title":"Germline pathogenic variants in cancer predisposition genes among women with invasive lobular carcinoma of the breast","volume":"39","author":"Yadav","year":"2021","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.clbc.2026.07.030_bib0020","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1200\/JCO.2007.12.5922","article-title":"CHEK21100delC genotyping for clinical assessment of breast cancer risk","volume":"26","author":"Weischer","year":"2008","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.clbc.2026.07.030_bib0021","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1023\/A:1005830230664","article-title":"BRCA2 hereditary breast cancer pathophenotype","volume":"44","author":"Marcus","year":"1997","journal-title":"Breast Cancer Res Treat"},{"issue":"7","key":"10.1016\/j.clbc.2026.07.030_bib0022","first-page":"680","article-title":"Risk of breast cancer in women with a CHEK2 mutation","volume":"364","author":"Cybulski","year":"2011","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.clbc.2026.07.030_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.gim.2023.100870","volume":"25","author":"Hanson","year":"2023","journal-title":"Genet Med"},{"issue":"3","key":"10.1016\/j.clbc.2026.07.030_bib0024","doi-asserted-by":"crossref","DOI":"10.1186\/bcr3205","article-title":"Breast carcinoma and Lynch syndrome: molecular analysis of tumors arising in mutation carriers, non-carriers, and sporadic cases","volume":"14","author":"Lotsari","year":"2012","journal-title":"Breast Cancer Res"},{"issue":"18","key":"10.1016\/j.clbc.2026.07.030_bib0025","first-page":"3976","article-title":"Comparative allelotype of in situ and invasive human breast cancer: high frequency of microsatellite instability in lobular breast carcinomas","volume":"55","author":"Aldaz","year":"1995","journal-title":"Cancer Res"},{"issue":"4","key":"10.1016\/j.clbc.2026.07.030_bib0026","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/ijc.2910640409","article-title":"Microsatellite instability and pathological aspects of breast cancer","volume":"64","author":"Contegiacomo","year":"1995","journal-title":"Int J Cancer"},{"issue":"9","key":"10.1016\/j.clbc.2026.07.030_bib0027","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1002\/(SICI)1097-0142(19960501)77:9<1836::AID-CNCR12>3.0.CO;2-0","article-title":"Molecular genetic evidence of the occurrence of breast cancer as an integral tumor in patients with the hereditary nonpolyposis colorectal carcinoma syndrome","volume":"77","author":"Risinger","year":"1996","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.clbc.2026.07.030_bib0028","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0304-3835(01)00448-7","article-title":"Contribution of germline MLH1 and MSH2 mutations to lobular carcinoma in situ of the breast","volume":"167","author":"Stone","year":"2001","journal-title":"Cancer Lett"}],"container-title":["Clinical Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152682092600131X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152682092600131X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T10:07:44Z","timestamp":1788948464000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S152682092600131X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":28,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S152682092600131X"],"URL":"https:\/\/doi.org\/10.1016\/j.clbc.2026.07.030","relation":{},"ISSN":["1526-8209"],"issn-type":[{"value":"1526-8209","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Effect of Germline Pathogenic Variants in the Upgrade Rate to Breast Cancer Among Patients Diagnosed With Atypical Lobular Hyperplasia and Lobular Carcinoma In Situ on Core Needle Biopsy","name":"articletitle","label":"Article Title"},{"value":"Clinical Breast Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clbc.2026.07.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}